Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples

Positive

AI Analysis

Summary

Minaris launched AgentSCREEN, a GMP-qualified NGS-based adventitious virus detection service for cell and gene therapy applications with a 28-day turnaround time and U.S.-based support.

Outcome Details

Launch of AgentSCREEN adventitious virus detection service using NGS technology

Importance:3/10

Sentiment:

0.60

service launchviral safety testingNGS technologycell therapygene therapyCDMOcell banks

Related Companies

$GMRE-PA

Read the original article

Published by PR Newswire Biotech on March 4, 2026 1:00 PM

Read Original